No Data
No Data
Intellia Hereditary Angioedema Candidate Meets Phase 2 Primary Endpoint
BofA Upgrades Editas to Buy, Cites Reni-cel Progress
Cantor Fitzgerald Reiterates Neutral on CRISPR Therapeutics
Jim Cramer: This Energy Stock Is A Buy, Stay Away From DexCom
Recursion Pharmaceuticals GAAP EPS of -$0.40 Misses by $0.02, Revenue of $14.42M Beats by $1.13M
Nvidia-backed Recursion to Acquire Exscientia in All-stock Deal
Forever 365 :
OceansWave : A lot of market moving events for this week.. so have you started to sell puts for NVDA? I am loading on the stock hahahah
Cow Moo-ney OP OceansWave : Haven’t haha. Waiting for lower price to sell put and to load up shares
OceansWave : Haha